Cancer survivors most frequently seek information about recurrence
the ONA take:
According to a new study published online first in the journal Cancer Epidemiology, Biomarkers & Prevention, researchers from the University of Pennsylavnia's Annenberg School of Communication have found that cancer survivors most frequently seek information about cancer recurrence, but information needs vary depending on cancer type.
For the study, researchers surveyed over 2,000 cancer survivors three times over a 3-year period. Participants were survivors of breast, colon, and prostate cancer. Results showed that across all participants, decreasing the risk for cancer recurrence was the most frequently researched topic.
In addition, survivors of breast cancer were more likely to seek information about late effects and their family members' risks than colon and prostate cancer survivors and were less likely to seek information about their risks of cancer recurrence in later years than during the year following diagnosis.
Researchers found that female colon cancer survivors were more likely to seek information about certain topics in later years than female breast cancer survivors, which may be due to more information about breast cancer and survivorship resources for breast cancer survivors being readily available.
The findings demonstrate various points that health care providers can educate their patients on cancer recurrence and survivorship.
Cancer survivors most frequently seek information about cancer recurrence.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|